261G000381 - IMIglucerase INJ 400 UI
TED · 304647-2026Award noticeawardedNo deadline given
Value
Estimated€734,692 · 734,692.4 EUR
Awarded€734,692 · 734,692.4 EUR
WinnerSANOFI-PRODUTOS FARMACÊUTICOS,LDA
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 22 | — | 2026-08-04 |
| GILEAD SCIENCES, LDA | 18 | — | 2026-07-28 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 14 | €834,956 | 2026-08-04 |
| NOVARTIS FARMA - PROD.FARM SA | 11 | — | 2026-08-04 |
| JANSSEN-CILAG FARMACEUTICA LDA | 9 | €371,730 | 2026-08-04 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33622000 Medical equipment & pharmaceuticalsDescription
IMIglucerase INJ 400 UI
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-05-05 | 261G000262 - IMIglucerase INJ 400 UI | Unidade Local de Saúde Santa Maria, E.P.E. PT | 99% |
| 2026-05-05 | 261G000314 - VELAglucerase alfa 400 U INJ | Unidade Local de Saúde Santa Maria, E.P.E. PT | 97% |
| 2026-07-28 | 2026/0098 - IMIGLUCERASE [400 U F/AMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 94% |
| 2026-05-05 | 261G000469 - INFLIximab 100 MG INJ BIOSSIMILAR (ZESSLY) | Unidade Local de Saúde Santa Maria, E.P.E. PT | 94% |
| 2026-07-21 | 261G000791 - BINIMEtinib 45 MG COMP | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-05-05 | 261G000505 - AVALGLUCOSIDASE ALFA INJ 100MG | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |